skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: ClinicalKey remover Base de dados/Biblioteca: EBSCO_MEDLINE Complete（医学期刊全文数据库） remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Ribrag, Vincent ; Lee, Seung Tae ; Rizzieri, David ; Dyer, Martin J.S. ; Fayad, Luis ; Kurzrock, Razelle ; Andritsos, Leslie ; Bouabdallah, Reda ; Hayat, Amjad ; Bacon, Larry ; Jiang, Yu ; Miah, Kowser ; Delafont, Bruno ; Hamid, Oday ; Anyanwu, Stephanie ; Martinez, Pablo ; Hess, Brian

Clinical lymphoma, myeloma and leukemia, 2021-05, Vol.21 (5), p.309-317.e3 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies
AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra ; Wang, Eunice S. ; Lane, Andrew A. ; Ali, Haris ; Stein, Anthony S. ; Yacoub, Abdulraheem ; Rizzieri, David ; Vasu, Sumithira ; Gupta, Vikas ; Lee, Sangmin ; Schiller, Gary J. ; Foran, James M. ; Taparia, Minakshi S. ; Rosenblat, Todd L. ; Walter, Roland B. ; Sieminski, Deborah ; Anant, Madhu ; Patnaik, Mrinal M. ; Mughal, Tariq I. ; Konopleva, Marina

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S246-S247 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies
Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra ; Wang, Eunice S. ; Lane, Andrew A. ; Ali, Haris ; Stein, Anthony S. ; Yacoub, Abdulraheem ; Rizzieri, David ; Vasu, Sumithira ; Gupta, Vikas ; Lee, Sangmin ; Schiller, Gary J. ; Foran, James M. ; Taparia, Minakshi S. ; Rosenblat, Todd L. ; Walter, Roland B. ; Sieminski, Deborah ; Anant, Madhu ; Patnaik, Mrinal M. ; Mughal, Tariq I. ; Konopleva, Marina

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S126 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Heyman, Benjamin ; Rizzieri, David ; Adams, David J. ; De Castro, Carlos ; Diehl, Louis ; Li, Zhiguo ; Moore, Joseph ; Beaven, Anne

Clinical lymphoma, myeloma and leukemia, 2018-10, Vol.18 (10), p.679-686 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
AML-373: Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
AML-373: Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

AML-373: Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial

Pemmaraju, Naveen ; Lane, Andrew ; Sweet, Kendra ; Stein, Anthony ; Vasu, Sumithira ; Blum, William ; Rizzieri, David ; Wang, Eunice ; Duvic, Madeleine ; Brooks, Christopher ; Sloan, J. Mark ; Rosenblat, Todd ; Akilov, Oleg ; Mughal, Tariq ; Lancet, Jeffrey ; Kantarjian, Hagop ; Konopleva, Marina

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S209-S210 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia

Advani, Anjali S. ; Tse, William ; Li, Hong ; Jia, Xuefei ; Elson, Paul ; Cooper, Brenda ; Ali-Osman, Francis ; Park, Jino ; Rao, Arati V. ; Rizzieri, David A. ; Wang, Eunice S. ; Cotta, Claudiu V. ; Kalaycio, Matt ; Sobecks, Ronald M. ; Rouphail, Basel ; Maciejewski, Jaroslaw P. ; Fensterl, Jaime ; Carew, Jennifer S. ; Foster, Bethany ; Rush, Mary Lynn ; Tripp, Barbara ; Adams, Donna ; Corrigan, Donna ; Griffiths, Elizabeth A. ; Sekeres, Mikkael A.

Clinical lymphoma, myeloma and leukemia, 2021-02, Vol.21 (2), p.113-118 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse

Advani, Anjali S ; Shadman, Mazyar ; Ali-Osman, Francis ; Barker, Andrew ; Rybicki, Lisa ; Kalaycio, Matt ; Sekeres, Mikkael A ; de Castro, Carlos M ; Diehl, Louis F ; Moore, Joseph O ; Beaven, Anne ; Copelan, Ed ; Sobecks, Ronald ; Talea, Parisa ; Rizzieri, David A

Clinical lymphoma, myeloma and leukemia, 2010-12, Vol.10 (6), p.473-476 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update

Mauro, Michael J., MD ; Dakhil, Shaker, MD ; Cortes, Jorge E., MD ; Rizzieri, David A., MD ; Bonifacio, Gaetano, MD ; Dautaj, Ilva ; Warsi, Ghulam ; Heinrich, Michael C., MD ; Goldberg, Stuart L., MD ; Catchatourian, Rosalind, MD ; Kuriakose, Philip, MD ; Radich, Jerald, MD

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.S37-S37 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

Rizzieri, David A ; Liu, Jane ; Traweek, S Thomas ; Miralles, G Diego

The Lancet (British edition), 1997-03, Vol.349 (9054), p.775-776 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia
Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia

Rizzieri, David ; LoRusso, Samantha ; Tse, William ; Khan, Khuda ; Advani, Anjali ; Moore, Joseph ; Karsten, Verena ; Cahill, Ann ; Gerson, Stanton L

Clinical lymphoma, myeloma and leukemia, 2010-06, Vol.10 (3), p.211-216 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2006  (5)
  2. 2006Até2009  (9)
  3. 2010Até2013  (15)
  4. 2014Até2018  (23)
  5. Após 2018  (13)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.